Business
Announcement on Convening 2024 Annual and Q1 2025 Performance and 2024 Cash Dividend Briefing
Announcement on Convening 2024 Annual and Q1 2025 Performance and 2024 Cash Dividend Briefing
About this update from Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A
Announcement on Convening 2024 Annual and Q1 2025 Performance and 2024 Cash Dividend BriefingThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment